Cambridge, UK-based biopharma company Ario Pharma says it has acquired the TRPA1 antagonist research program previously owned by privately-held Italian...
Read moreAuxilium Pharmaceuticals said Tuesday it is cutting 30 percent of its workforce, about 190 jobs, as part of a restructuring...
Read moreSanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) approved use of...
Read moreTeva Pharma announced positive new data from Phase III studies of the company’s anti-IL5 monoclonal antibody, reslizumab, in patients with...
Read moreTo help address the growing costs and long development timelines facing vaccine manufacturers, Lonza is announcing the launch of the...
Read moreCore Phase III clinical trial program complete; BIL showed consistent HbA1c superiority against comparators Lilly expects U.S. and European regulatory...
Read moreCleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company...
Read moreFirst PD-1 blocking drug to receive agency approval The U.S. Food and Drug Administration today granted accelerated approval to...
Read moreNew Jersey firm sold unapproved and improperly labeled drugs Various unapproved and improperly labeled drug products that were marketed,...
Read more'No evidence of disease activity' (NEDA), the ultimate treatment goal in MS, is currently assessed by measuring relapses, MRI lesions...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
